OQROGet OQRO Pro
Insider trade

Insmed (INSM)CEO sold ~$215K

William Lewis, CEO at Insmed, sold ~$215K of Insmed shares.

~$215K
Approx. value · 1,938 sh @ $110.91
234K
Holds after · shares reported
Traded
Aug 4, 2025
Filed
Aug 6, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 5, 2025InsiderOfficer sold ~$138K of INSM shares in the open market
  2. Jun 10, 2025Insider · 3 peopleInsiders: 8 sales (~$10.8M)
  3. Jun 11, 2025Insider · 2 peopleInsiders: 6 sales (~$11.1M)
  4. Jun 16, 2025Insider · 2 peopleInsiders: 10 sales (~$14.6M)
  5. Jun 16, 2025CongressDisclosed purchase of INSM — reported range $1,001 - $15,000
  6. Jun 23, 2025Insider · 1 personInsiders: 2 sales (~$5.9M)
  7. Jul 1, 2025Insider · 1 personInsiders: 3 sales (~$672K)
  8. Jul 7, 2025Insider · 1 personInsiders: 2 sales (~$5.5M)
  9. Jul 7, 2025CongressDisclosed partial sale of INSM — reported range $1,001 - $15,000
  10. Jul 11, 2025InsiderOfficer sold ~$72K of INSM shares in the open market
  11. Jul 15, 2025Insider · 2 peopleInsiders: 4 sales (~$795K)
  12. Jul 21, 2025Insider · 1 personInsiders: 2 sales (~$6.0M)
  13. Aug 4, 2025 · this disclosureInsiderCEO sold ~$215K of INSM shares in the open market

What came next

  1. Aug 4, 2025Insider · 2 peopleInsiders: 3 sales (~$1.5M)
  2. Aug 8, 2025CongressDisclosed partial sale of INSM — reported range $1,001 - $15,000
  3. Aug 12, 2025InsiderDirector sold ~$1.22M of INSM shares in the open market
  4. Aug 14, 2025Insider · 1 personInsiders: 3 sales (~$1.3M)
  5. Aug 18, 2025Insider · 1 personInsiders: 3 sales (~$881K)
  6. Aug 19, 2025Insider · 1 personInsiders: 2 sales (~$3.2M)
  7. Aug 20, 2025InsiderDirector sold ~$1.29M of INSM shares in the open market
  8. Sep 2, 2025Insider · 2 peopleInsiders: 12 sales (~$30.4M)
  9. Sep 12, 2025Insider · 2 peopleInsiders: 5 sales (~$12.6M)
  10. Sep 22, 2025CongressDisclosed partial sale of INSM — reported range $1,001 - $15,000
  11. Oct 3, 2025CongressDisclosed sale of INSM — reported range $1,001 - $15,000
  12. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Insmed

For Insmed, OQRO holds 24 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INSM page.

Other recent filings by William Lewis, Chair and CEO

The full history of William Lewis, Chair and CEO is on the profile page.

How this filing works

Other disclosures at Insmed

Everything OQRO holds on this company is on its INSM page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data